Overview

Effects of Etanercept on the Heart, Veins and Thickness of Certain Major Arteries In Ankylosing Spondylitis Patients

Status:
Terminated

Trial end date:
2011-10-01

Target enrollment:

Participant gender:

Summary

Study to assess whether etanercept therapy is able to increase flow-mediated vasodilatation in AS, and whether etanercept can modify the intima-media thickness (IMT) in these patients

Phase:

Phase 4

Details

Lead Sponsor:

Pfizer

Collaborator:

Lincoln Medical and Mental Health Center

Treatments:

Etanercept